Related Experiment Video
Updated: Aug 11, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Gaucher disease protects against tuberculosis
Jingwen Fan1,2, Victoria L Hale2, Lindsey T Lelieveld3
1Molecular Immunity Unit, Cambridge Institute of Therapeutic Immunology and Infectious Diseases, Department of Medicine, University of Cambridge, Cambridge CB2 0QH, UK.
The Gaucher disease mutation GBA1 N370S enhances tuberculosis resistance in zebrafish by increasing microbicidal activity. This explains its prevalence in Ashkenazi Jews, as heterozygotes are susceptible, but homozygotes gain protection.
Area of Science:
- Genetics
- Immunology
- Microbiology
Background:
- Gaucher disease results from GBA1 gene mutations, causing lysosomal storage. This disease and related lysosomal disorders are prevalent in Ashkenazi Jews.
- A proposed hypothesis suggests GBA1 mutations offer a selective advantage, specifically protection against tuberculosis.
Purpose of the Study:
- To investigate the protective mechanism of the GBA1 N370S mutation against tuberculosis using a zebrafish model.
- To explore the role of glucosylsphingosine in macrophage lysosomes in conferring resistance.
Main Methods:
- Utilized a zebrafish model of Gaucher disease.
- Analyzed the impact of the GBA1 N370S mutation on tuberculosis resistance.
- Examined the microbicidal activity of glucosylsphingosine in macrophage lysosomes.
Main Results:
- The GBA1 N370S mutation significantly increased resistance to tuberculosis in the zebrafish model.
- Glucosylsphingosine within macrophage lysosomes demonstrated microbicidal activity against tuberculosis.
- Heterozygotes for the mutation remained susceptible to tuberculosis, unlike homozygotes.
Conclusions:
- The study reveals a mechanistic basis for tuberculosis protection conferred by the GBA1 N370S mutation.
- The findings provide biological plausibility for the selection of GBA1 N370S due to protection against tuberculosis, a historical major cause of mortality.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

